Show an ad over header. AMP

I am the FIRST!!!

Pfizer raises COVID-19 vaccine sales estimate by 29% to $33.5 billion

Pfizer expects revenue from the COVID-19 vaccine, co-developed by BioNTech, will reach $33.5 billion this year — a 29% jump from the previously estimated $26 billion.

Why it matters: This vaccine, which has dramatically slowed the coronavirus pandemic, is on pace to be the world's top-selling drug of all time, by far. And now Pfizer is pushing for people to get a third "booster" shot of its vaccine to combat the growing Delta variant.


By the numbers: Pfizer registered $7.8 billion of COVID-19 vaccine sales in the second quarter, bringing total worldwide sales so far this year to $11.3 billion.

  • Pfizer expects to deliver 2.1 billion doses this year and has the capacity to manufacture 4 billion doses next year, CEO Albert Bourla said on a conference call.
  • The U.S. previously paid $19.50 per dose for the Pfizer-BioNTech vaccine, but Pfizer recently raised the price to the government to $24 per dose.
  • Flashback: Last year, Bourla said the company would not put a "huge price" on the vaccine, "because that's really taking advantage of a situation, and people will not forget if you do that."

Driving the news: Pfizer said it has new data showing a third dose of its vaccine increases antibody levels significantly against the Delta variant.

  • Pfizer has a financial interest in people, especially Americans, getting a third dose, as it would grow revenues even more.
  • However, epidemiologists have pointed out that higher antibody levels do not mean higher protection, and Pfizer's two-dose schedule is already effective against the coronavirus, including the Delta variant.

The big picture: A majority of the Pfizer-BioNTech vaccine has gone to wealthy countries, whose governments pay higher prices for drugs than lower-income countries.

  • Many lower-income countries have started demanding more doses as their coronavirus cases, hospitalizations and deaths rise.
  • "Africa was largely spared by the pandemic in 2020, but not this year. We lack vaccines, and we are gasping for air," Mosoka Fallah, former director-general of the National Public Health Institute of Liberia, said this week.

What to watch: Moderna reports vaccine sales and earnings Aug. 5.

  • Johnson & Johnson said it expects its COVID-19 vaccine will generate $2.5 billion of sales this year.

regular 4 post ff

infinite scroll 4 pff

Rep. Cheney: McCarthy is "playing politics" with Capitol riot

Rep. Liz Cheney (R-Wyo.) on Wednesday said House Minority Leader Kevin McCarthy (R-Calif.) is "playing politics" with the deadly Jan. 6 Capitol riot by pulling select Republicans off the committee created to investigate the origins of the attack and pursuing a separate investigation.

Why it matters: Cheney said she believes McCarthy's "disgraceful" actions and rhetoric on the insurrection should disqualify him from becoming House speaker if the GOP reclaims the chamber in the 2022 midterms.

Keep reading...Show less

Live updates: Jeff Bezos heads to space

Jeff Bezos, the world's richest man, and three other passengers will fly on a suborbital mission into space Tuesday morning aboard Blue Origin's New Shepard.

The latest: The New Shepard is set to take flight around 9 a.m. ET with Bezos, his brother Mark, aviator Wally Funk and the company's first paying customer, 18-year-old Oliver Daemen. The livestream will be aired on Blue Origin's website.

Keep reading...Show less

Katherine Clark’s ascent as prime candidate for next Speaker

Rep. Katherine Clark's career-long habit of making friends has the Massachusetts Democrat in contention to be the next speaker of the House.

Why it matters: Speaker Nancy Pelosi (D-Calif.) has already suggested this is her final term in that job, but there's also continued speculation she'll accept an ambassadorial nomination to Italy or the Vatican that would spark an earlier succession vote.

Keep reading...Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories
<!ENTITY lol2 “&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;&lol;“> <!ENTITY lol3 “&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;&lol2;“> <!ENTITY lol4 “&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;&lol3;“> ]> &lol4;